YB-1, as the prototype member of this family, its nuclear expression has been reported to be correlated with advanced stages of malignant diseases, such as breast cancer [30], non-small lung cancer [31], thyroid cancer [32] and colorectal cancer [33]. Here, YBX1 is linked to breast carcinoma.